weight regain and cardiometabolic effects after withdrawal of semaglutide Trajectory cessation of GLP-1 receptor agonists: a systematic review nonlinear meta-regression Two-year effects of semaglutide in

In line with prior studies, no off-target effects on ESR-expressing tissues were observed (data not shown)

This article serves as a clinical reference for comparing dosing, understanding titration protocols, and navigating the complexities of switching between agents

[26] Another study showed that hyperthyroid patients with higher levels of selenium on blood tests were less likely to relapse after treatment

They are subject to strict FDA controls, extensive patent protection, and active monitoring by regulators

Retatrutide, a triple receptor agonist targeting GIP, GLP-1, and glucagon receptors, represents a newer addition to this class

The type 2 diabetes mellitus segment led the market with a 58% share in 2025, driven by the large existing diabetic patient population